hydroxyproline has been researched along with Cancer of Colon in 9 studies
Hydroxyproline: A hydroxylated form of the imino acid proline. A deficiency in ASCORBIC ACID can result in impaired hydroxyproline formation.
hydroxyproline : A proline derivative that is proline substituted by at least one hydroxy group.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Examples of this latter category include the changes in urinary hydroxyproline output in patients with bone metastases or the altered levels of serum acute phase proteins in neoplasia in general." | 3.66 | The monitoring role of plasma CEA alone and in association with other tumor markers in colorectal and mammary carcinoma. ( Capp, M; Coombes, RC; Cooper, EH; Laurence, DJ; Neville, AM; Patel, S; Turberville, C, 1978) |
| "In this malignancy, the HCG level suggests the diagnosis and stage, confirms response to therapy, and predicts relapse." | 2.37 | Tumor markers: value and limitations in the management of cancer patients. ( Bates, SE; Longo, DL, 1985) |
| "Analysis of colon cancer tumor and adjacent tissue revealed hydroxyproline modifications associated with extracellular matrix degradation." | 1.36 | TagRecon: high-throughput mutation identification through sequence tagging. ( Chambers, MC; Dasari, S; Ham, AJ; Slebos, RJ; Tabb, DL; Zimmerman, LJ, 2010) |
| "3-Hyp-containing peptides in cancer patients might be destroyed by the elevated peptidase levels found in these patients." | 1.36 | ELISA measurement for urinary 3-hydroxyproline-containing peptides and its preliminary application to healthy persons and cancer patients. ( Hayashi, T; Imamura, Y; Inagaki, Y; Itoh, J; Kashiwazaki, K; Kitagawa, Y; Maruta, A; Matsuyama, S; Okazaki, I; Saito, J; Sato, A; Wada, N; Watanabe, T, 2010) |
| "The hydroxyproline levels were higher in the IGF-I and the IGF-I +5-FU groups as a result of the stimulating act of IGF-I." | 1.35 | Effect of IGF-I on healing of colonic anastomoses in rats under 5-FU treatment. ( Betsis, D; Demetriades, H; Kanellos, I; Koliakos, G; Lambrou, I; Pramateftakis, MG; Zacharakis, E; Zaraboukas, T, 2008) |
| "The development of human tumors is accompanied very often by tumor-associated phenomena such as production of tumor-derived substances, production of certian substances in response to the tumor or immunological reactions." | 1.26 | Biological markers of human tumors and monitoring of cancer treatment. ( Nissen, E; Tanneberger, S; Ziegenbein, R, 1979) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (44.44) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (33.33) | 29.6817 |
| 2010's | 2 (22.22) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aarts, F | 1 |
| Bleichrodt, RP | 1 |
| de Man, B | 1 |
| Lomme, R | 1 |
| Boerman, OC | 1 |
| Hendriks, T | 1 |
| Dasari, S | 1 |
| Chambers, MC | 1 |
| Slebos, RJ | 1 |
| Zimmerman, LJ | 1 |
| Ham, AJ | 1 |
| Tabb, DL | 1 |
| Saito, J | 1 |
| Imamura, Y | 1 |
| Itoh, J | 1 |
| Matsuyama, S | 1 |
| Maruta, A | 1 |
| Hayashi, T | 1 |
| Sato, A | 1 |
| Wada, N | 1 |
| Kashiwazaki, K | 1 |
| Inagaki, Y | 1 |
| Watanabe, T | 1 |
| Kitagawa, Y | 1 |
| Okazaki, I | 1 |
| Zacharakis, E | 2 |
| Demetriades, H | 1 |
| Pramateftakis, MG | 1 |
| Lambrou, I | 1 |
| Zaraboukas, T | 1 |
| Koliakos, G | 1 |
| Kanellos, I | 1 |
| Betsis, D | 1 |
| Zmudzinski, J | 1 |
| Potkanska, A | 1 |
| Kapolka, D | 1 |
| Chocilowska, D | 1 |
| Malinowski, S | 1 |
| Bode, MK | 1 |
| Karttunen, TJ | 1 |
| Mäkelä, J | 1 |
| Risteli, L | 1 |
| Risteli, J | 1 |
| Tanneberger, S | 1 |
| Nissen, E | 1 |
| Ziegenbein, R | 1 |
| Neville, AM | 1 |
| Patel, S | 1 |
| Capp, M | 1 |
| Laurence, DJ | 1 |
| Cooper, EH | 1 |
| Turberville, C | 1 |
| Coombes, RC | 1 |
| Bates, SE | 1 |
| Longo, DL | 1 |
1 review available for hydroxyproline and Cancer of Colon
| Article | Year |
|---|---|
Tumor markers: value and limitations in the management of cancer patients.
Topics: Acid Phosphatase; Adrenocorticotropic Hormone; Alkaline Phosphatase; alpha-Fetoproteins; Breast Neop | 1985 |
8 other studies available for hydroxyproline and Cancer of Colon
| Article | Year |
|---|---|
The effects of adjuvant experimental radioimmunotherapy and hyperthermic intraperitoneal chemotherapy on intestinal and abdominal healing after cytoreductive surgery for peritoneal carcinomatosis in the rat.
Topics: Abdominal Wall; Anastomosis, Surgical; Animals; Antibiotics, Antineoplastic; Chemotherapy, Cancer, R | 2008 |
TagRecon: high-throughput mutation identification through sequence tagging.
Topics: Algorithms; Cell Line, Tumor; Chromatography, Liquid; Colonic Neoplasms; Computational Biology; Data | 2010 |
ELISA measurement for urinary 3-hydroxyproline-containing peptides and its preliminary application to healthy persons and cancer patients.
Topics: Adult; Aged; Aged, 80 and over; Antibodies; Biomarkers, Tumor; Case-Control Studies; Colonic Neoplas | 2010 |
Effect of IGF-I on healing of colonic anastomoses in rats under 5-FU treatment.
Topics: Anastomosis, Surgical; Animals; Antimetabolites, Antineoplastic; Collagen; Colon; Colonic Neoplasms; | 2008 |
[Free and total hydroxyproline in the blood of patients with gastrointestinal neoplasms].
Topics: Adult; Aged; Biliary Tract Neoplasms; Colonic Neoplasms; Digestive System Neoplasms; Esophageal Neop | 1981 |
Type I and III collagens in human colon cancer and diverticulosis.
Topics: Adult; Aged; Collagen; Colon; Colonic Neoplasms; Diverticulum, Colon; Female; Humans; Hydroxyproline | 2000 |
Biological markers of human tumors and monitoring of cancer treatment.
Topics: Alkaline Phosphatase; alpha-Fetoproteins; Bone Neoplasms; Carcinoembryonic Antigen; Choriocarcinoma; | 1979 |
The monitoring role of plasma CEA alone and in association with other tumor markers in colorectal and mammary carcinoma.
Topics: Breast Neoplasms; C-Reactive Protein; Carcinoembryonic Antigen; Colonic Neoplasms; Enzymes; Female; | 1978 |